Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection-Reference-Cited by-同舟云学术

Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

Published:2019-06-14 Issue:1 Volume:20 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Sablik Kasia A.^ORCID,Clahsen-van Groningen Marian C.,Looman Caspar W. N.,Damman Jeffrey,van Agteren Madelon,Betjes Michiel G. H.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-019-1385-z.pdf

Reference32 articles.

1. Pirsch JD, Miller J, Deierhoi MH, Vincenti F. Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 kidney transplant study group. Transplantation. 1997;63(7):977–83.

2. Merion RM, White DJ, Thiru S, Evans DB, Calne RY. Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med. 1984;310(3):148–54.

3. Ciancio G, Burke GW, Miller J. Induction therapy in renal transplantation : an overview of current developments. Drugs. 2007;67(18):2667–80.

4. Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–62.

5. Fehr T, Gaspert A. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale. Transpl Int. 2012;25(6):623–32.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Incidence of Antibody-Mediated Rejection Is Age-Related, Plateaus Late After Kidney Transplantation, and Contributes Little to Graft Loss in the Older Recipients;Transplant International;2023-12-22

2. Multiomic profiling of transplant glomerulopathy reveals a novel T-cell dominant subclass;Kidney International;2023-12

3. Lowering maintenance immune suppression in elderly kidney transplant recipients; connecting the immunological and clinical dots;Frontiers in Medicine;2023-07-12

4. Prognosis and Treatment for Active and Chronic Antibody-Mediated Rejection in Renal Transplant Recipients; Single Center Experience;Transplantation Proceedings;2022-09

5. Causes of Kidney Graft Failure in a Cohort of Recipients With a Very Long-Time Follow-Up After Transplantation;Frontiers in Medicine;2022-06-06